UBS Group
TBXU

UBS Group’s Direxion Daily Biotech Top 5 Bull 2X ETF TBXU Stock Holding History

UBS Group’s Portfolio TBXU Stock Details TBXU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.7K Buy
+706
New +$21.3K ﹤0.01% 8082

Other funds holding TBXU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

UBS Group's TBXU Position: Q2 2026 in Review

UBS Group opened a new position in Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) in Q2 2026: 706 shares worth $22.7K. The stake represents ﹤0.01% of the portfolio and ranks #8082 among its holdings.

4 funds tracked by Wall St. Rank hold TBXU as of Q2 2026.

  • UBS Group held 706 shares of Direxion Daily Biotech Top 5 Bull 2X ETF worth $22.7K as of Q2 2026.
  • Direxion Daily Biotech Top 5 Bull 2X ETF was a new UBS Group position in Q2 2026.
  • Direxion Daily Biotech Top 5 Bull 2X ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8082 holding.
  • 4 funds tracked by Wall St. Rank held Direxion Daily Biotech Top 5 Bull 2X ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.